Background: Implementation of newborn hearing screening programmes is widely recommended and programme organisational designs may differ in practice. The objective of this article was to establish an overview of the newborn hearing screening programmes in the 28 countries of the European Union on four topics (policydecision, financing, general designs, organisational features). Methods: National or regional programme coordinators completed an online self-administered questionnaire focusing on protocol description and programme organisation. Results: Thirty-nine key informants, representing 24 countries, from national or regional levels completed the questionnaire. Newborn hearing screening programmes are or will be shortly implemented largely in the European Union countries. Levels of policy decision-making and organisational decisions are diverse (national, regional or combined). Designs of the programmes (number of steps before diagnosis referral, single or dual target group protocol) highly varied. However, common organisational elements were observed: hearing screening tests are often performed by nursing staff, in hospitals and early in life. This pattern does not apply when a screening protocol is specifically implemented for newborns with risk factor(s) for hearing impairment or admitted to neonatal intensive care units. Hearing test financing frequently involved public sources, including government and public health funds. Conclusion: Despite the same goal of early identification of hearing-impaired children, there is a high level of diversity in programmes, including policy decisions, financing, general designs and pragmatic organisational choices (e.g. professionals involved, location or time for screening, number of steps in the protocol). Further investigations should analyse these differences in relation to the programmes' contexts and outcomes. 
Introduction
A t least one in 1000 newborns are affected by hearing impairment, 1, 2 and the studies of hearing-impaired toddlers highlight the benefits of early diagnosis and intervention. 3, 4 Early intervention enhances language and speech outcomes as well as cognition and socioemotional development. [3] [4] [5] [6] Universal newborn hearing screening is recommended by international committees 1, 7, 8 , and recommendations from the Joint Committee on Infant Hearing include screening before 1 month of age, establishing a diagnosis before 3 months, and initiating interventions as soon as possible after diagnosis (no later than 6 months). 7 A universal newborn hearing screening programme is essential to meet these goals. In practice, although the shared purpose is to diagnose hearing impaired children early, different organisational designs could be implemented (e.g. the kind of tests, number of screening steps before diagnostic referral, newborns' age when tests are performed, the professionals that administer the tests, screening location, or the targeted population). [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] This study provides an overview of the organisational designs of national and regional newborn hearing screening programmes in the 28 European Union (EU) countries and highlights their similarities and differences in level of policy-decision, financing, general designs, and organisational features. The ultimate goal is to initiate a network of shared practices in order to improve knowledge and practices. This study excluded screening programmes from levels lower than regional (e.g. cities).
Methods

Study design and key informants identification
This overview is derived from a descriptive, cross-sectional study that collected information using a questionnaire about newborn hearing screening programmes in EU countries. We used several strategies to identify appropriate key informants from each country. First, we contacted authors of publications related to 'newborn hearing screening' in each country in the PubMed database. Second, in the absence of relevant results at the first stage, we examined the 'Newborn Hearing Screening' Congress abstracts (Como, Italy, 2008 and 2010) to identify national or regional programme representatives who attended the congresses. Third, if a key informant remained unidentified, we contacted the national representative at the European Federation of Audiology Societies (EFAS) to obtain contact information for the person(s) responsible for the country's newborn hearing screening programme. In the absence of response from EFAS representatives, we searched the Internet. Key informants were required to have knowledge about the global organisation of the newborn hearing screening programme, its protocol, and main outcomes (e.g. screening test coverage or failure rates). We identified key informants between May 2014 and January 2015; most of them were identified thanks to EFAS representatives.
Data collection
Data were collected using an online self-administered questionnaire (see Supplementary material). Each key informant was emailed a personalised invitation with direct access to a SurveyMonkey Õ questionnaire. The first invitation was sent in January 2015 and followed by two follow-up emails (February 2015 and April 2015) . Access to the questionnaire ended May 15, 2015 .
The questionnaire consisted of five distinctive parts: key informant identification, general newborn hearing programme information (e.g. time of programme initiation, financing, institutions involved), programme protocol description and organisation, hearing impairment risk factor management, and the programme's main outcomes. Research topics were selected because they are central elements in newborn hearing screening programme organisation 7 and because they were raised in the management of the regional programme in our country. This article presents only general information, protocols, and organisation.
The questionnaire was built on theoretical concepts of screening programmes and on practical concepts used in newborn hearing screening: flow diagram of screening process, components of screening stages, conditions for diagnosis referral 23, 24 . The practical concepts were exhaustive in the predefined responses of closed-ended questions in the questionnaire. Nonetheless, the closed-ended questions were used in combination with an openended field to supplement responses if necessary. The questionnaire was pre-tested on a Belgian regional programme and, based on the feedback we received, was found to cover all the aspects crucial to the programme implementation. To avoid misunderstanding-related bias, the main concepts of screening test ('applied systematically to a targeted population') and audiological evaluation ('referral after the screening test(s) to confirm the diagnosis') were explicitly defined.
Questionnaire data management
Forty-one questionnaires were collected, among the 89 national and regional invitations that were sent (participation rate: 46.1%). Two questionnaires were merged because they concerned the same country, one for newborns from well-baby nurseries and one for newborns admitted to neonatal intensive care units (NICUs). One questionnaire was excluded because it was incomplete. Questionnaires related to upcoming programmes (n = 3) were answered as if protocols had been implemented. Thus, 39 questionnaires were included.
Newborn hearing screening programme-related variables
This study used variables built on closed-and open-ended responses, which were categorised as follows. Organisational features comprise tests used, kind of professionals, location, and test timing. Tests used for newborn hearing screening included (automated) otoacoustic emissions ((a)OAE), (automated) auditory brainstem responses ((a)ABR), or auditory steady-state responses (ASSR) (alone or in combination). The (a)OAE test explores cochlear (inner ear) function, while (a)ABR and ASSR explore the entire auditory pathway from inner ear to central auditory function. 25 The professionals administering tests were nursing staff (nurses, midwifes, nursery nurses); audiologists or speech therapists; a combination of the first two categories; and other professionals. Test location was 'inside' (maternity ward, NICU, or audiological outpatient) or 'outside' (home or well-baby organisation) the hospital. First test timing was based on open-ended questions and categorised into two groups: first test performed between birth and the fourth day of life, or after the fourth day. The fourth-day cut-off was utilised because it appeared in responses as an upper range for early life testing. A third category, 'before discharge from NICU' emerged from the responses.
Protocols are designed as single target group (STG) protocol when all targeted newborns follow the same protocol, or as dual target group (DTG) protocol when two sub-protocols are concurrently running. In DTG protocols, newborns are directed in the subprotocols according to either hospitalisation ward or potential hearing impairment risk factors at birth; consequently, two subgroups are encountered: the first concerns newborns either from well-baby nurseries or without risk factors (labelled the 'largest sub-group') and the second concerns newborns either from NICUs or with risk factors (labelled the 'smallest sub-group'). The two sub-protocols are the 'screening' component of the programme, before diagnosis assessment and all the targeted newborns in DTG protocols are referred in one of the sub-protocols.
Descriptive analysis
Programme organisation (national or regional), programme characteristics (financing, targeted population, general design), and screening tests and audiological diagnosis organisation (professionals performing the tests, test location, kind of tests, conditions for test performance) were described. Proportions were presented and, when useful, numbers were specified as the result of the small number of respondents. We presented organisational information according to STG or DTG protocols (in each sub-protocol) and summarised organisational features whatever the number of screening steps before diagnosis referral.
Results
Key informant and general programme characteristics
Thirty-nine key informants from regional or national levels completed the survey. Fifteen national newborn hearing screening programmes were reported (Bulgaria, Croatia, Cyprus, Estonia, Finland, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Netherlands, Poland, Romania and Slovenia). Exceptions were Finland, where the newborn hearing screening runs independently in hospitals without national coordination, and Romania, where the programme is progressively implemented in hospitals and did not cover the entire country at the time of the survey. Twenty-four key informants reported from a regional level and represented nine countries (Austria: one region; Belgium: two regions; Czech Republic: one region; Denmark: two regions; France: nine regions; Germany: four regions; Spain: two regions; Sweden: one region; United Kingdom: two regions). There were two situations in regional reporting. In one, the regional government makes policy-related decisions about newborn hearing screening (e.g. Belgium or Spain), thereby deciding whether to implement programmes and screening organisational modalities. In the second, executive decisions about screening implementation occur at a national level but regions are in charge of implementation (e.g. France or Germany). Four countries did not participate to the survey: Greece (where the coordinator indicated that a national programme was recently initiated), Malta (where the Health Commissioner recently recommended screening all newborns), Portugal (no national screening) and Slovakia (national programme).
Programmes' main features
Of the 39 reported programmes, only 3 (7.7%) were not implemented at the time of the survey and will be implemented in the following months. Of the 36 implemented programmes, 22 (61.1%) had been operating for more than 10 years ( 2005).
Screening tests were exclusively government financed in 15 of 39 programmes (38.5%), 14 financed by public health insurance funds (35.9%), 5 by the government and another funding source (12.8%), and 5 by other sources (hospitals or private and public health insurance funds) (12.8%), respectively. Audiological diagnosis following screening tests were exclusively financed by public health funds in 16 of 39 programmes (41.0%), 13 financed by government (33.3%), 5 by government and another funding source (12.8%) and 5 by other sources (hospitals or private insurance in combination or not with public health insurance) (12.8%), respectively. In most programmes, screening tests and audiological evaluations had similar funding sources.
All the programmes were 'universal', except one that targeted all newborns except those hospitalised in NICUs. Screening protocols (before referral for diagnosis assessment) were differently designed among the European Union. First, no protocols were defined in 3 of 39 programmes (7.7%), meaning that each hospital or service determines the modalities of the screening process. Second, a protocol was defined: a STG protocol (unique protocol) was proposed in 13 of 39 (33.3%) programmes whereas 23 of 39 programmes (59.0%) consisted of DTG protocol, where newborns are separated in two sub-protocols running simultaneously (figure 1). In 14 of the 23 DTG protocols, the sub-protocols are applied according to the hospitalisation ward at birth and in 9 of the 23 DTG protocols, the sub-protocols are applied according to the absence/presence of hearing impairment risk factors. Thus, in the DTG protocols (n = 23), the 'largest sub-group' consists of newborns from well-baby nurseries (n = 14) or without hearing impairment risk factors (n = 9) and the 'smallest sub-group' consists of newborns from NICUs (n = 14) or presenting hearing impairment risk factors (n = 9).
The number of screening steps before the referral for the diagnosis is shown in figure 1 . Among the 13 STG protocols, 10 proposed two-step screening. In contrast, in DTG protocols (n = 23), two-step screening was proposed in 15 sub-protocols for the largest subgroup and in 10 for the smallest sub-group. Two programmes did not propose a screening test in cases of risk factors or NICU admissions and directly referred newborns for an audiological diagnosis (figure 1).
Screening organisational characteristics (before referral for diagnosis assessment)
Despite diversity in screening designs (SGT versus DGT; number of steps), some common organisational features are encountered: nursing staff most often administer screening tests (alone or in association with other kinds of professionals), and most tests are performed before the fifth day of life and in-hospital (over 80% of tests). Major differences related to the tests performed and concerned the smallest sub-group of newborns in DTG protocols, where (a)OAE alone are very rarely performed and first tests are less frequently performed during the first four days of life (35.0% versus 84.6% or 100.0%). Indeed, this sub-protocol was established for newborns with special care needs (from NICUs or presenting hearing impairment risk factor(s)). Consequently, the organisational design for this sub-group differs from the other groups (table 1) .
Audiological evaluation organisation
In 23 of 39 programmes (59.0%), an audiological evaluation was performed in cases of referral from earlier in the screening process when there were unsatisfactory results for one or both ears. Further, in 11 programmes (28.2%), an audiological evaluation was performed in case of hearing impairment risk factor(s), regardless of screening process results. Audiological tests performed at this stage used multiple methods in 22 of 39 programmes (56.4%). When one or two tests were performed, the (a)ABR test was frequently mentioned either alone or combined with others (30.8%). Most programmes recommended performing the audiological evaluation during the first 12 weeks of life (86.5%). The professionals who administered the test varied widely between programmes and no longer involved nursing staff (table 2) .
Discussion
This study provides an insight into newborn hearing screening programmes in EU countries, on four topics (level of policydecision, financing, general design and organisational features of the programmes). As recommended 1,7,8, universal newborn hearing screening programmes are widely implemented in the EU. However, Figure 1 Screening designs and number of steps in the newborn hearing screening protocols in the European Union, before the referral for the diagnosis assessment while some programmes are both decided and implemented at a national level, others are determined and implemented through policy at a regional level or determined nationally and regionally implemented. The level of policy decision-making is unrelated to country size but is inherent to the country's political organisation. Previous studies on this topic have not highlighted this major policy difference. 15, 26 Policy-based investments are also seen in financing: governments or public health insurance funds are involved in most programmes, either alone or in combination with another funding source. From a public health perspective, screening programme accessibility should be the highest for all newborns to contribute to a high-quality programme and to sustain equity. 23 To meet this goal, there should be standard investments from public authorities without residual financing from parents or optional private insurance, which is not the case in all investigated programmes. There should also be no financial barriers for diagnosing and admitting hearingimpaired children to intervention services in the recommended timeframe. 27 Beyond availability of screening programmes, accessibility should thus be targeted for all newborns in the EU and in all components of the programme (screening, diagnosis and potential intervention).
A key result of this study is diversity in programme design and organisation, which supports other investigations about newborn hearing or blood screening. 26, 28 STG or DTG protocols were observed, as well as protocols involving between one and three steps. The number of steps aimed to lower the referral rate of newborns to audiological diagnosis by reducing the false-positive rate, particularly in programmes using (a)OAE. 29 However, numerous repetitions of screening tests should not delay the diagnosis of neonatal hearing impairment, and the number of screening tests before diagnosis referral should balance with the risk of lost to follow-up newborns, which is one major weakness of this kind of screening. 30 Performing the screening tests before hospital discharge will lower the risk of lost to follow-up children. 31 Our results highlight the will to lower the referral rate and the lost to follow-up newborns with two-step programmes and early in life inhospital screening tests. Organisational choices in the programmes have thus practical implications on a public health issue.
Despite this organisational diversity, three common elements are more frequently encountered: performing in-hospital screening tests, testing early in life (before the fifth day), and administration by nursing professionals. First, nursing professionals are often key elements in the screening process, and are frequently involved in hearing screening programmes. 15, 32 There is a need for welltrained nursing staff with basic knowledge in audiology and about the newborn hearing screening process. Second, test timing has 14, 17 hospital screening is largely implemented; reasons for this choice should be analysed in addition to hospital length stay and organisation of postnatal care strategies among the EU countries.
These three common elements are not applicable to the newborns with risk factor(s) or admitted to NICUs (smallest group in DTG protocols). Due to the specific features of this group, specific organisational elements were found. The (a)ABR is particularly recommended because it investigates the entire auditory pathway beyond the cochlea (these newborns present a higher risk of retrocochlear hearing impairment), and thus contributes to adequate identification of hearing-impaired children. Although screening tests are frequently delayed in this group due to priority given to other vital health problems, they should be performed before discharge 1, 7 as in almost one of every two protocols reported. DTG protocols allow greater flexibility according to the child's health, but hinder uniformity in local practices. Conversely, STG protocols propose a uniform organisation but require a more intensive and longer test. Flexibility and test features should thus be balanced in each programme.
The limitations of this study are similar to all studies based on self-administered questionnaires in terms of quality and truthfulness of responses. To improve confidence in the data collected, we attended carefully to key informant identification. Moreover, beyond this study, we noticed the lack of standardised definitions for the concepts used in newborn hearing screening programmes (e.g. screening process, how to count steps); a definition of these concepts was thus included in the questionnaire. Particular elements also differ between countries such as the 'audiologist' profession: some countries require a medical degree, but others do not. 15 To avoid a rigid questionnaire, some open-ended fields were available, providing the opportunity to elaborate on responses. Although this study did not include all EU programmes, almost all countries were represented. The diversity of the organisational patterns reported in our results would likely remain unchanged through an exhaustive data collection. We did not present an overview of scientific publications about newborn hearing screening programmes per country, because our methodology was not built with this purpose. Moreover, although most key informants identified themselves in the questionnaire as 'programme coordinator', search in Pubmed led to the identification of only a few key informants, highlighting the small number of peer-reviewed publications by the key informants in this field (statement based on one database).
Analysis of a screening programme across EU countries is innovative. This study utilised a descriptive design and proposes a pragmatic description of EU newborn hearing screening programmes. It highlights diversity in programmes in terms of their design, reflecting differences in national and regional health care policies, as well as financial structures and organisational decisions. It is the first step in developing a network of shared practices across countries, and to learn from others' experiences thanks to future studies across European countries, such as already recommended for newborn screening of rare diseases. 28 Like other preventive health programmes, newborn hearing screening programmes aimed to balance available resources (e.g. human, material) to achieve the highest care quality. To meet this goal, further investigations should explore the abovementioned differences and integrate information about context and outcomes in analysis (e.g., location of birthing or length of stay in birthing hospital, professionals' education, available funding, organisation of perinatal health care, and preventive care). Consequently, programme differences should be explored in relation to outcomes and organisational designs to improve the understanding of newborn hearing screening programmes, and initiate performance analyses among European countries.
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Key points
Financing newborn hearing screening tests and audiological diagnosis frequently involved public sources including government or public health funds. The level of policy-related decision-making is heterogeneous between programmes, ranging from national to regional in terms of decisions to implement programmes and how to organise them. Newborn hearing screening programmes designs across the European Union are diverse (single or dual target group protocols, number of screening tests before diagnosis referral). Common organisational elements in the programmes were that nursing staff typically perform screening tests, in hospitals and early in life; however, these features do not apply in protocols for newborns admitted to neonatal intensive care units or those with risk factors for hearing impairment.
